0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

D. Doi; H. Konishi; K. Yoneyama; T. Yahata; K. Fujita; H. Nakayama; S. Kodama; Y. Aoki; H. Asakura; T. Takeshita; K. Tanaka

doi:10.1136/ijgc-00009577-200610001-00185

Article info

ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006

0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

Authors

D. Doi Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan PubMed articles Google scholar articles
H. Konishi Department of Obstetrics and Gynecology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan PubMed articles Google scholar articles
K. Yoneyama Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan PubMed articles Google scholar articles
T. Yahata Department of Obstetrics and Gynecology, School of Med. Niigata University, Niigata, Japan PubMed articles Google scholar articles
K. Fujita Department of Obstetrics and Gynecology, School of Med. Niigata University, Niigata, Japan PubMed articles Google scholar articles
H. Nakayama Department of Gynecology, Kanagawa Prefecture Cancer Center, Yokohama, Japan PubMed articles Google scholar articles
S. Kodama Department of Gynecology, Niigata Cancer Center Hospital, Niigata, Japan PubMed articles Google scholar articles
Y. Aoki Department of Obstetrics and Gynecology, University of The Ryukyu, Okinawa, Japan PubMed articles Google scholar articles
H. Asakura Department of Obstetrics and Gynecology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan PubMed articles Google scholar articles
T. Takeshita Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan PubMed articles Google scholar articles
K. Tanaka Department of Obstetrics and Gynecology, School of Med. Niigata University, Niigata, Japan PubMed articles Google scholar articles

Citation

Doi D, Konishi H, Yoneyama K, et al

0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

International Journal of Gynecologic Cancer 2006;16:652.

Online issue publication

December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password